Alexandre Trifilieff

Author

Novartis (United Kingdom)

Also Known As

Alexandre Trifilieff, Trifilieff, Alexandre

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Novartis (United Kingdom)Novartis (Switzerland)Novartis Institutes for BioMedical Research University of Turin Université de Strasbourg

About

Alexandre Trifilieff is an author at Novartis (United Kingdom) specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.9K
2	Allergy	7	7	979
3	Biochemistry	3	3	93
4	Natural Sciences	1	1	33
5	Allergy Medicine	1	1	145

Alexandre Trifilieff

Publications

Citations

H-Index

Page 1

	Year	Citations
IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger Stéphane Ferretti, Olivier Bonneau, Gerald Dubois, The Journal of Immunology AsthmaInflammatory Lung DiseaseLung InflammationImmunologyImmune Regulation	2003	535
Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function Muriel Laffargue, Ronan Calvez, Peter M. Finan, Immunity Signal TransductionMolecular PhysiologySignaling PathwayMast Cell DisorderImmunology	2002	287
In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1 H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action Cliff H. Battram, Steven J. Charlton, Bernard Cuenoud, Journal of Pharmacology and Experimental Therapeutics	2006	161
PPAR‐<i>α</i> and ‐<i>γ</i> but not ‐<i>δ</i> agonists inhibit airway inflammation in a murine model of asthma: <i>in vitro</i> evidence for an NF‐<i>κ</i>B‐independent effect Alexandre Trifilieff, Anne Bench, Marcus Hanley, British Journal of Pharmacology	2003	147
In vivo models of lung neutrophil activation. Comparison of mice and hamsters Randolph Corteling, Daniel F. Wyss, Alexandre Trifilieff BMC Pharmacology Acute Lung InjuryInflammationLung DepositionInflammatory Lung DiseaseLung Inflammation	2002	146
Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment Alexandre Trifilieff, Ahmed Z. El‐Hashim, Claude Bertrand American Journal of Physiology-Lung Cellular and Molecular Physiology AsthmaLung InflammationAllergy MedicineSteroid TreatmentImmunology	2000	145
Inhibition of Th1- and Th2-Mediated Airway Inflammation by the Sphingosine 1-Phosphate Receptor Agonist FTY720 Elżbieta Sawicka, Cláudia Zuany‐Amorim, Corinne Manlius, The Journal of Immunology AsthmaInflammationTh2 CellsOral Fty720 TreatmentSignal Transduction	2003	143
The Th2 Cell Cytokines IL-4 and IL-13 Regulate Found in Inflammatory Zone 1/Resistin-Like Molecule α Gene Expression by a STAT6 and CCAAT/Enhancer-Binding Protein-Dependent Mechanism Adrian M. Stütz, Louise A. Pickart, Alexandre Trifilieff, The Journal of Immunology	2003	130
The Influence of Receptor Kinetics on the Onset and Duration of Action and the Therapeutic Index of NVA237 and Tiotropium David A. Sykes, Mark R. Dowling, Juliet Leighton-Davies, Journal of Pharmacology and Experimental Therapeutics	2012	120
Inducible Nitric Oxide Synthase Inhibitors Suppress Airway Inflammation in Mice Through Down-Regulation of Chemokine Expression Alexandre Trifilieff, Yasushi Fujitani, F Mentz, The Journal of Immunology AsthmaInflammatory Lung DiseaseLung InflammationImmunologyEosinophilic Disorder	2000	119

Page 1